Patients who have been labeled with a penicillin allergy may now have a chance at being delabeled without the need for specialist intervention or extensive testing, according to a recent study. Ibrahim Shah, MD, from the Indiana University School of Medicine, presented findings from a quality-improvement project conducted at a community hospital where 56 inpatients
Health
The PREDICT prognostication tool has been evaluated for its ability to estimate overall survival (OS) in a large independent U.S. dataset of breast cancer patients. Researchers from Case Western Reserve University School of Medicine in Cleveland conducted the study using data from the National Cancer Database (NCDB). Their findings, published in the Journal of the
Despite the limited representation of Hispanic physicians in the medical field, a group of passionate TikTok creators has emerged as prominent voices in the medfluencer community. These individuals are not only making an impact by sharing their medical expertise, but they are also advocating for aspiring Hispanic medical professionals. Whether it’s providing inspiration, educational content,
The addition of dexamethasone to the treatment regimen for tuberculous (TB) meningitis in heavily immunosuppressed HIV-positive patients has been a topic of interest and debate. A recent randomized controlled trial conducted in low-resource settings aimed to determine the impact of dexamethasone in improving survival rates and other outcomes among this patient population. This article critically
The recent Psych Congress 2023 brought together experts in the field of psychiatry, shedding light on the current state of schizophrenia research. Among the speakers was Dr. Peter Weiden, a clinical professor of psychiatry at the Renaissance School of Medicine at Stony Brook University in New York. In his session titled “State of the Science:
Semaglutide 2.4 mg (Wegovy) has demonstrated notable improvements in outcomes for patients with moderately reduced and preserved ejection fraction in heart failure (HFmrEF, HFpEF) related to obesity. This compelling information was revealed through a prespecified secondary analysis of the STEP-HFpEF trial. According to Javed Butler, MD, MPH, MBA, of the Baylor Scott and White Research
Being an expert witness can be a daunting task, as I experienced firsthand. The experience left me disillusioned, not because of the grueling cross-examination, the questioning of my qualifications, or the inadequate compensation. No, my disillusionment stemmed from the need to defend the medical profession’s age-old tradition rooted in the “art” of medicine. This incident
A recent small randomized study conducted at the Hospital Universitario La Paz in Madrid has shed light on the impact of continuous positive airway pressure (CPAP) on the progression of eye disease in sleep apnea patients with non-proliferative diabetic retinopathy. The study aimed to evaluate the effectiveness of long-term CPAP use in reducing eye disease
In the treatment of axial spondyloarthritis (axSpA), researchers have been exploring the potential of bimekizumab, an interleukin-17 (IL-17) blocker. Recent studies have revealed promising efficacy results, with more than 60% of patients classified as responders after 1 year of continuous treatment with bimekizumab. However, despite its potential, the future availability of bimekizumab in the U.S.
In a recent study conducted by Mark Effron, MD, and colleagues, the effectiveness and safety of enteric-coated aspirin for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) were evaluated. The study aimed to determine whether the enteric coating had any impact on the incidence of myocardial infarction, stroke, all-cause death, and major bleeding events. By